Health Sciences In The Media

Fractal noise machines or programs that generate different "colors" of sound promise to help people sleep better.

A story suggests medical residents consider the Integrative Medicine Elective Rotation at the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson.

The CDC didn’t find a link between the vaccines and hundreds of new cases of tinnitus, a debilitating ringing in the ears, but some scientists say it must do more to investigate.

Breast cancer is the most frequently diagnosed female cancer worldwide. Encouragingly, new therapeutic options are continuously emerging, which in most cases are tailored according to the specific subtype of breast cancer.

Legislation that would allow certain Arizona psychologists to prescribe medications for mental health disorders appears dead, for now. A November 2020 report on Arizona's behavioral health workforce from the Center for Rural Health is cited.

Efforts to develop a cure for Valley fever could involve the use of live attenuated vaccines, which elicit a robust immune response – including T cells – but also run the risk of replicating uncontrollably in people with compromised immune systems. Preventing that is now possible.

An article cites a study of the most hygienic hand-drying methods that was led by Kelly Reynolds, PhD, MSPH, professor and chair of the Department of Community, Environment and Policy in the Mel and Enid Zuckerman College of Public Health.

The U.S. Preventive Services Task Force did not include people age 65 and older in its recommendation last year to screen adults for anxiety. The task force noted that questionnaires used to screen for anxiety may be unreliable for older adults.

Michael Grandner, PhD, MTR, CBSM, FAASM, director of the Sleep and Health Research Program and associate professor at the College of Medicine – Tucson, writes about the importance of building some buffer time between work and bedtime to ensure the best possible night's sleep.

There are no HIV vaccines currently available, and after the recent failures of three experimental vaccines in development, there are now zero candidates in late-stage trials.